Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.4 HKD | +1.72% | +5.66% | -22.10% |
Apr. 30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
Apr. 29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- Official Publications